Euro-BioImaging welcomes IVIM Technology to the Industry Board


Published January 8, 2025
Category

Euro-BioImaging is delighted to announce that IVIM Technology has joined the Euro-BioImaging Industry Board (EBIB) effective 1st January 2025. The company will be represented by their CMO and Head of Sales, Sujin Park.

Sujin Park, CMO

IVIM Technology's membership further strengthens the collaboration between imaging companies and researchers in our network, particularly benefiting Nodes working with pre-clinical imaging. As a pioneer in intravital microscopy, IVIM Technology offers advanced live animal imaging solutions and training to the scientific community.

Their addition to the Industry Board diversifies the industry expertise accessible to the Euro-BioImaging community. By welcoming a second company specializing in pre-clinical imaging, we aim to stimulate exchange within the biomedical research community, potentially fostering new collaborations and innovative ways of knowledge sharing.

IVIM Technology will present at our Tech Exchange webinar on 7th February 2025.

Euro-BioImaging looks forward to a fruitful collaboration with IVIM Technology.

contributed by Claudia Pfander


More news from Euro-BioImaging

Junel Solis, Finish Advanced Microscopy Node, at work analysing microscope data.

July 24, 2025

Meet Junel Solis, Head Image Data Analyst at the Finnish Advanced Microscopy Node

As part of our ongoing series spotlighting the talented scientists working at the Euro-BioImaging Nodes, we sat down with Junel Solis, an expert in…

Looking at the neuronal cells in the hydrogel with two-photon microscopy. 

July 21, 2025

International collaboration to support Parkinson’s disease research

Would learning to use the most cutting-edge imaging instruments help you answer your scientific question? Could world-class technology accelerate your research? We spoke to…

Telemedicine and human Bladder recovery concept. Neutral color palette, copy space for text.

July 21, 2025

PHIRE: a photoacoustic imaging and AI-based theranostic approach for cancer

Bladder cancer is the 10th most common cancer globally, with more than half million new cases every year, but it is the most expensive…